Research Keyword: fungal epidemiology

A Rare Battle: Multidisciplinary Care for a Child with Rhino-Orbital Cerebral Mucormycosis in Somali Region of Ethiopia

A 12-year-old girl with poorly controlled diabetes developed a serious fungal infection in her sinuses and eye that spread to her brain. Despite the infection being extremely dangerous, doctors successfully treated her using multiple approaches including antifungal medication, surgery to remove infected tissue, and careful management of her blood sugar. She recovered and went home, though she lost vision in one eye.

Read More »

Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic

During the COVID-19 pandemic, fungal infections became a major health concern, especially in hospitalized patients. Treatments for COVID-19, such as steroids and immunosuppressive drugs, weakened patients’ immune systems, making them vulnerable to serious fungal infections like those caused by Candida auris. Current antifungal medications have significant side effects and many fungi are developing resistance, so scientists are urgently seeking safer and more effective antifungal treatments.

Read More »

Evaluation of Clinical, Microbiological Profiles and Management Patterns with Outcomes of Patients with Fungal Isolates in An Intensive Care Unit of A Tertiary Care Center: A Prospective Observational Study

This study examined fungal infections in patients staying in intensive care units at a hospital. Researchers found that diabetes was the most common risk factor, and a fungus called Candida tropicalis was the most frequently isolated organism from urine samples. Many of the fungal strains were resistant to fluconazole, a common antifungal medication, suggesting doctors need to choose different treatments based on which drugs the fungi are resistant to.

Read More »

The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis

This study examined fungal blood infections in newborns across low- and middle-income countries, analyzing data from nearly 11,000 cases. Researchers found these infections occur more frequently and have higher death rates in poorer countries compared to wealthy nations. They identified that most infections are caused by Candida fungus species, and many of these fungi have become resistant to fluconazole, the most commonly used treatment drug.

Read More »

Superficial Fungal Infections in the Pediatric Dermatological Population of Northern Poland

This study examined fungal skin infections in children and teens in Northern Poland over six years, finding that about 1 in 5 children tested had a fungal infection. Different types of fungal infections were more common at different ages—younger children more often had scalp infections, while teenagers more often had foot and nail infections. The study found that children living in rural areas had higher infection rates than those in cities, suggesting that environmental factors play an important role in fungal infection patterns.

Read More »

Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity

Researchers studied fungi living in beach sand and seawater along Iran’s Persian Gulf and Sea of Oman coastlines to understand potential health risks. They found that dangerous fungi, particularly Aspergillus species, were present at levels exceeding safe thresholds for swimmers and beach visitors. Many of these fungi showed resistance to common antifungal medications, which is concerning for people with weakened immune systems. The study suggests that beaches need better monitoring and sanitation programs to protect public health.

Read More »

Spectrum of Fungal Infections in Continuous Ambulatory Peritoneal Dialysis: A 20-Year Retrospective Study From a Tertiary Care Center

This study examined fungal infections in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) over 20 years at an Indian medical center. Researchers found that yeast infections, particularly Candida tropicalis, were more common than mold infections, with Aspergillus flavus being the most frequent mold. The study identified several rare and emerging fungi causing these serious infections and tested their susceptibility to antifungal medications. Results show that removing the dialysis catheter combined with appropriate antifungal treatment is crucial for patient survival.

Read More »

Mapping Histoplasma spp. in bats and cave ecosystems: evidence from midwestern Brazil

Researchers found that caves in Brazil harbor a dangerous fungus called Histoplasma that can cause a serious lung disease in humans. The study detected the fungus in soil samples from several caves and in multiple bat species living in those caves. The findings show which caves are most dangerous and emphasize the need for warning signs and protective measures for cave visitors and workers in the region.

Read More »

Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature

Candida krusei is a dangerous yeast that causes a serious lung infection called empyema, where pus collects around the lungs. This infection is particularly difficult to treat because the yeast is resistant to common antifungal drugs like fluconazole and can form protective biofilms. This systematic review identified only ten cases of this rare infection in the medical literature, showing how uncommon but serious it is, and found that patients need aggressive treatment with multiple antifungal medications combined with surgical drainage to survive.

Read More »

Persistent Candidemia: Predictors and Outcomes in a Multicenter Matched Analysis

This study examined cases where fungal infections caused by Candida persisted in the bloodstream even after starting antifungal treatment. Researchers compared 46 patients with persistent infections to 92 control patients without persistent infections across three major medical centers. Patients with persistent candidemia were younger, more likely to be female, had more health complications, and sadly had much higher death rates (54% vs 31%) within 90 days. The findings suggest that certain patient characteristics and fungal species types may help identify those at higher risk of persistent infections.

Read More »
Scroll to Top